Abeona CCO sells 12,606 shares in open-market trade
Abeona Therapeutics Inc. Chief Commercial Officer Madhav Vasanthavada reported an open-market sale of 12,606 shares of common stock at a weighted average price of $6.9637 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Abeona Therapeutics Inc. Chief Commercial Officer Madhav Vasanthavada reported an open-market sale of 12,606 shares of common stock at a weighted average price of $6.9637 per share. After this transaction, he directly holds 290,623 shares, indicating that only a small portion of his position was sold.
Insider Trade Summary
Net Seller: 12,606 shares
Net Sell
1 txn
Insider
Vasanthavada Madhav
Role
Chief Commercial Officer
Sold
12,606 shs ($88K)
Share of Position Sold
4.2%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 12,606 | $6.9637 | $88K |
Holdings After Transaction:
Common Stock — 290,623 shares (Direct)
Holdings Before and After:
Common Stock, 303,229 to 290,623 shares (Direct)
Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
- F1. Represents shares withheld to satisfy tax withholding obligations upon vesting of restricted stock awards.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.86 to $7.04 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Key Figures
Shares sold: 12,606 shares
Weighted average sale price: $6.9637 per share
Post-transaction holdings: 290,623 shares
+2 more
5 metrics
Shares sold
12,606 shares
Open-market sale of common stock on reported transaction date
Weighted average sale price
$6.9637 per share
Average price across multiple trades in the reported sale
Post-transaction holdings
290,623 shares
Common stock held directly after the sale
Trade price range
$6.86–$7.04 per share
Range of individual trade prices within the reported transaction
Net shares sold
12,606 shares
Net change in position from this Form 4, per summary data
Key Terms
open-market sale, weighted average price, non-derivative, Form 4, +1 more
5 terms
open-market sale financial
"reported an open-market sale of 12,606 shares of common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
non-derivative financial
"The filing reports a non-derivative open-market sale of common stock"
Form 4 regulatory
"What insider transaction did Abeona Therapeutics (ABEO) disclose in this Form 4?"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
transaction code "S" regulatory
"coded as an “S” transaction. This indicates shares previously owned outright"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Abeona Therapeutics (ABEO) disclose in this Form 4?
Abeona Therapeutics reported that Chief Commercial Officer Madhav Vasanthavada executed an open-market sale of 12,606 shares of common stock. This sale was reported as a non-derivative transaction involving directly held shares.
What type of transaction is reported in this Abeona Therapeutics (ABEO) Form 4?
The filing reports a non-derivative open-market sale of common stock, coded as an “S” transaction. This indicates shares previously owned outright were sold rather than options or other derivative securities being exercised.
Does the Abeona Therapeutics (ABEO) Form 4 mention how the sale was executed?
Yes. A footnote states the reported price is a weighted average because the shares were sold in multiple trades. These trades occurred at prices ranging from $6.86 to $7.04 per share, all on the same transaction date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
